Management of angioedema without urticaria in the emergency department (Q38314955)

2 September 2017

1 reference

title

Management of angioedema without urticaria in the emergency department (English)

1 reference

2 September 2017

1 reference

Maria Pedrosa

1

0 references

Alicia Prieto-García

object named as

Alicia Prieto-García

series ordinal

2

0 references

Marta Ferrer

1 reference

ORCID Public Data File 2021

author name string

Anna Sala-Cunill

series ordinal

3

1 reference

2 September 2017

Spanish Group for the Study of Bradykinin-Mediated Angioedema (SGBA) and the Spanish Committee of Cutaneous Allergy (CCA)

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 December 2014

1 reference

2 September 2017

1 reference

2 September 2017

volume

46

1 reference

2 September 2017

issue

8

1 reference

2 September 2017

page(s)

607-618

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

2 September 2017

1 reference

Nonallergic angioedema: role of bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Aspirin and NSAID sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

IgE, mast cells, basophils, and eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Immunologic messenger molecules: cytokines, interferons, and chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Allergic inflammation: cellular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Clinical Immunology Review Series: An approach to the patient with angio-oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Differential release of mast cell mediators and the pathogenesis of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

The plasma bradykinin-forming pathways and its interrelationships with complement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

The pathophysiology of hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Bradykinin-mediated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: a multifactorial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Enzymatic assays for the diagnosis of bradykinin-dependent angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Disease expression in women with hereditary angioedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Angiotensin-converting enzyme inhibitors and angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Bradykinin and the pathophysiology of angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Successful treatment of a facial attack of angioedema with icatibant in a patient with idiopathic angioedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Pathogenesis, diagnosis, and treatment of aspirin intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

The role of fiberoptic nasopharyngoscopy in the management of the acute airway in angioneurotic edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Predicting airway risk in angioedema: staging system based on presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Diagnosis and management of angioedema with abdominal involvement: A gastroenterology perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Angiotensin–converting enzyme (ACE) inhibitors and angio–oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Upper airway considerations in hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Acute urticaria and angioedema: diagnostic and treatment considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Diagnosis and treatment of urticaria and angioedema: a worldwide perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Anaphylaxis: Recent advances in assessment and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Fresh frozen plasma for the treatment of hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Angiotensin-converting enzyme inhibitor-related angioedema: recognition and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

Hereditary angio-edema involving the gastrointestinal tract: CT findings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07853890.2014.949300

10.3109/07853890.2014.949300

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference